ArticleEinstein (Sao Paulo, Brazil)2022

Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study.

Raghunatha Reddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.